Results 231 to 240 of about 20,045 (250)
Some of the next articles are maybe not open access.
Pneumocystis jirovecii Pneumonia
Infectious Disease Clinics of North America, 2010Pneumocystis jirovecii has gained attention during the last decade in the context of the AIDS epidemic and the increasing use of cytotoxic and immunosuppressive therapies. This article summarizes current knowledge on biology, pathophysiology, epidemiology, diagnosis, prevention, and treatment of pulmonary P jirovecii infection, with a particular focus ...
Louis-Jean Couderc +6 more
openaire +4 more sources
2010
The ascomycete fungus Pneumocystis jirovecii (previously called Pneumocystis carinii) is the cause of pneumocystis pneumonia (PCP) in humans, which occurs largely among people with impaired CD4+ T-lymphocyte function or numbers, e.g those infected with HIV, or organ transplant recipients taking therapeutic immunosuppressive agents.
Robert F. Miller, Laurence Huang
openaire +1 more source
The ascomycete fungus Pneumocystis jirovecii (previously called Pneumocystis carinii) is the cause of pneumocystis pneumonia (PCP) in humans, which occurs largely among people with impaired CD4+ T-lymphocyte function or numbers, e.g those infected with HIV, or organ transplant recipients taking therapeutic immunosuppressive agents.
Robert F. Miller, Laurence Huang
openaire +1 more source
Pneumocystis jirovecii Pneumonia
2020The life cycle of Pneumocystis jirovecii is complicated. It tries to find a damaged immune system to replicate, leading to life-threatening complications. With the treatment of immunosuppressive drugs, Pneumocystis jirovecii pneumonia has become a common opportunistic infection in non-AIDS populations. A CD4+ lymphocyte count of
Jing Feng +4 more
openaire +2 more sources
Pneumocystis jirovecii genotypes and granulomatous pneumocystosis
Médecine et Maladies Infectieuses, 2006This study describes the initial data concerning molecular typing of Pneumocystis jirovecii in a patient having developed granulomatous Pneumocystis pneumonia (PCP). Three types, B(1)a(3), B(1)a(4), B(1)b(2), were identified. All three had been described in reports concerning patients with common diffuse alveolar PCP.
Totet, A. +5 more
openaire +4 more sources
Pneumocystis jirovecii (carinii)
2015This chapter cites Pneumocystis jirovecii (PJP), formerly known as Pneumocystis carinii, as an opportunistic pathogen that causes pneumonia in the immunocompromised individual. It explains how the disease caused by PJP occurs when both cellular and humoral immunity are impaired.
Shelley A. Gilroy, Nicholas J. Bennett
openaire +2 more sources
Pneumocystis jirovecii and Pneumocystosis
2017Pneumocystis jirovecii pneumonia (PcP or pneumocystosis) remains a major cause of respiratory illness among immunocompromised patients, especially those infected with the human immunodeficiency virus (HIV). P. jirovecii infection has also been detected in healthy individuals and people with chronic lung diseases, raising the possibility that the ...
Olga Matos +2 more
openaire +2 more sources
Drug Resistance in Pneumocystis jirovecii
2009Pneumocystis jirovecii is a fungus that appears to be transmitted from human to human by aerosol spread. There is no animal reservoir and probably no environmental reservoir for the species which infects humans. Trimethoprim-sulfamethoxazole is the drug of choice for both treatment and prevention of disease in humans.
Henry Masur +3 more
openaire +2 more sources
Outbreak-Causing Fungi: Pneumocystis jirovecii
Mycopathologia, 2019Pneumocystis jirovecii pneumonia (PCP) is an important cause of morbidity in immunocompromised patients, with a higher mortality in non-HIV than in HIV patients. P. jirovecii is one of the rare transmissible pathogenic fungi and the only one that depends fully on the host to survive and proliferate.
Maud Gits-Muselli +6 more
openaire +3 more sources